跳至主要内容
临床试验/ISRCTN02309506
ISRCTN02309506已完成未知

Crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea

Papworth Hospital NHS Foundation Trust (UK)0 个研究点目标入组 90 人开始时间: 2010年3月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged greater than or equal to 18 years, either sex
  • 2. Obstructive sleep apnoea-hypopnoea confirmed by respiratory polysomnogram with apnoea-hypopnoea index (AHI) 5 to 30/hours
  • 3. Excessive daytime sleepiness (ESS) greater than or equal to 11 and/or participant reported sleepiness
  • 4. Sufficient teeth to allow satisfactory device retention
  • 5. Ability to give written informed consent

排除标准

  • 1. Primary central sleep apnoea
  • 2. Coexistent sleep disorder or drug treatment considered likely to have significant impact on symptoms (especially sleepiness) or MAD effectiveness
  • 3. Severe and/or unstable cardiovascular disease judged by clinician to warrant immediate continuous positive airway pressure (CPAP)
  • 4. Other medical or psychiatric disorder judged likely to adversely interact with MAD or confound interpretation of its effectiveness
  • 5. Significant periodontal disease or tooth decay; partial or complete edentulism; presence of fixed orthodontic devices
  • 6. Temporomandibular joint pain or disease
  • 7. Severe bruxism
  • 8. Restriction in mouth opening or advancement of mandible
  • 9. Respiratory failure
  • 10. Inability to give informed consent or comply with the protocol
  • 11. Pregnant women
  • 12. Any other significant clinical contra-indication, e.g. disabling sleepiness upgrading the obstructive sleep apnoea-hypopnoea (OSAH) to severe

研究者

发起方
Papworth Hospital NHS Foundation Trust (UK)

相似试验